As more than 200,000 Americans have died from COVID-19, cancer patients – who are often immunocompromised and depend on regular treatments to prevent the progression of the disease – are particularly at risk for dying by the potentially deadly virus. "Most cancers themselves put patients into immune-compromised states. That state is profoundly reinforced and worsened by the treatments that we give," said Dr. Julie Bauman, deputy director of the University of Arizona Cancer Center.

Calendar, Announcements, college-specific pages are among the new features in this one-stop shop for Health Sciences news and information.

The novel coronavirus may be able to block pain and mask the illness in its early stages as it spreads throughout the body, a new study suggests. The team, from the University of Arizona Health Sciences, says the findings may explain why nearly half of all patients with COVID-19 experience no symptoms.

Julie Bauman is an oncologist and the deputy director of the University of Arizona Cancer Center. As a specialist who works with cancer patients every day, she understands their unique vulnerability to COVID-19. Due to this increased risk, doctors at the UA Cancer Center noticed a decrease in patients coming in for preventive screenings at the height of the pandemic, resulting in an increase in advanced cases arriving at the cancer center as the number of coronavirus cases declines.

The virus that causes COVID-19 acts as a pain reliever, suggests the findings of a new study that could offer “one possible explanation for the unrelenting spread” of the disease, researchers said. Researchers with the University of Arizona Health Sciences said SARS-CoV-2, the virus that causes COVID-19, may inadvertently function as a pain reliever, which “may explain why nearly half of all people who get COVID-19 experience few or no symptoms, even though they are able to spread the disease.

President Donald Trump continues to tout an experimental treatment he received for COVID-19 as a cure for the disease despite an absence of evidence to back up that claim. Immunobiologist Deepta Bhattacharya at the University of Arizona College of Medicine - Tucson said there's a theoretical chance the treatment could prevent people from developing their own immunity. The monoclonal antibodies may block the part of the virus that the immune system needs to "see" to develop protective immunity. If that's the case, the immune system wouldn't develop its own longer-lasting antibodies.

The University of Arizona researchers have discovered that COVID-19 can give a false sense of pain relief. Many people with COVID-19 don’t show symptoms right away or are asymptomatic entirely, which sparked the interest of researchers at the U of A.

Research from the University of Arizona Health Sciences found that people who suffer from migraines may benefit from something called green light therapy which is exactly what it sounds like. Listeners call in to the live Dana & Parks Show and share their experience living with migraines.

The $2.3 million National Institutes of Health grant will enable Dr. Alicia Allen to explore how women’s hormones influence postpartum opioid relapse and if they may be used as a preventative strategy.

Skipping radiation and receiving less chemotherapy may become the new standard of care for some lymphoma patients, according to a recent collaborative study led by a Daniel Persky, MD, associate director for clinical investigations at the UArizona Cancer Center.